Third, immunofluorescence assays were followed to investigate the expression levels and subcellular distributions of mTOR and its active form phosphorylated mTOR (pmTOR) in prostate, colon, breast, and lung cancer cell lines. Here, MTOR is linked to lung carcinoma.